Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
ORLANDO, Fla., Nov. 15, 2017 (GLOBE NEWSWIRE) -- MEDITE Cancer Diagnostics, Inc. (OTCQB:MDIT) (the “Company”), specializing in the development, manufacturing and marketing of molecular biomarkers...
-
ORLANDO, Fla., Nov. 14, 2017 (GLOBE NEWSWIRE) -- MEDITE Cancer Diagnostics, Inc. (OTCQB:MDIT) (the “Company”), specializing in the development, manufacturing and marketing of molecular biomarkers...
-
ORLANDO, Fla., Nov. 08, 2017 (GLOBE NEWSWIRE) -- MEDITE Cancer Diagnostics, Inc. (OTCQB:MDIT) (the “Company”), specializing in the development, manufacturing and marketing of molecular biomarkers...
-
ORLANDO, Fla., Oct. 03, 2017 (GLOBE NEWSWIRE) -- MEDITE Cancer Diagnostics, Inc. (OTCQB:MDIT) (the “Company”), specializing in the development, manufacturing and marketing of molecular biomarkers...
-
ORLANDO, FL--(Marketwired - Aug 14, 2017) - MEDITE Cancer Diagnostics, Inc. (OTCQB: MDIT) (the "Company"), specializing in the development, manufacturing and marketing of molecular biomarkers and...
-
ORLANDO, FL--(Marketwired - Jul 27, 2017) - MEDITE Cancer Diagnostics, Inc. (OTCQB: MDIT), specializing in the development, manufacturing and marketing of molecular biomarkers and premium medical...
-
ORLANDO, FL--(Marketwired - May 10, 2017) - MEDITE Cancer Diagnostics, Inc. (OTCQB: MDIT) (the "Company") specializing in the development, manufacturing and marketing of molecular biomarkers and...
-
ORLANDO, FL--(Marketwired - Apr 28, 2017) - MEDITE Cancer Diagnostics, Inc. (OTCQB: MDIT) (the "Company") specializing in the development, manufacturing and marketing of molecular biomarkers and...
-
ORLANDO, FL--(Marketwired - Apr 27, 2017) - MEDITE Cancer Diagnostics, Inc. (OTCQB: MDIT) (the "Company"), specializing in the development, manufacturing, and marketing of molecular biomarkers and...
-
ORLANDO, FL--(Marketwired - Mar 7, 2017) - MEDITE Cancer Diagnostics, Inc. (OTCQB: MDIT) ("MEDITE" or the "Company"), a medical technology company specializing in the development, engineering,...